mTOR: good, bad, or ugly?

Cardiovasc Res. 2012 Aug 1;95(3):261-2. doi: 10.1093/cvr/cvs201. Epub 2012 Jun 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors*
  • Animals
  • Antibiotics, Antineoplastic / toxicity*
  • DNA Damage*
  • Doxorubicin / toxicity*
  • Energy Metabolism / drug effects*
  • Heart Diseases / chemically induced*
  • Male
  • Myocytes, Cardiac / drug effects*
  • Oxidative Stress / drug effects*
  • Protein Kinase Inhibitors / toxicity*
  • Signal Transduction / drug effects*

Substances

  • Antibiotics, Antineoplastic
  • Protein Kinase Inhibitors
  • Doxorubicin
  • AMP-Activated Protein Kinases